Labcorp Holdings Inc's fundamentals are relatively healthy, and its growth potential is high.Its valuation is considered fairly valued, ranking 17/78 in the Healthcare Providers & Services industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 299.75.In the medium term, the stock price is expected to remain stable.Despite an average stock market performance over the past month, the company shows strong fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
Labcorp Holdings Inc's Score
Industry at a Glance
Industry Ranking
17 / 78
Overall Ranking
87 / 4592
Industry
Healthcare Providers & Services
Support & Resistance
Relevant data have not been disclosed by the company yet.
Score Analysis
Current score
Previous score
Analyst Rating
Based on
21
analysts
Buy
Current Rating
299.753
Target Price
+15.32%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
Labcorp Holdings Inc Highlights
StrengthsRisks
Labcorp Holdings Inc. provides comprehensive laboratory services that help doctors, hospitals, pharmaceutical companies, researchers and patients make clear and confident decisions. The Company provides insights and accelerates to improve health and improve lives through its unparalleled diagnostics and drug development capabilities. The Company operates through two segments: Diagnostics Laboratories (Dx) and Biopharma Laboratory Services (BLS). The Diagnostics Laboratories segment includes routine testing and specialty/esoteric testing. Dx operates through a network of patient service centers, branches, rapid response laboratories, primary laboratories, and specialty laboratories. The Biopharma Laboratory Services segment consists of early development research laboratories and central laboratory services. The Company is focused on four primary specialty testing areas, such as oncology, women's health, autoimmune disease, and neurology.
High Dividend
The company is a high dividend payer, with the latest dividend payout ratio of 32.56%.
Undervalued
The company’s latest PE is 25.77, at a low 3-year percentile range.
Institutional Buying
The latest institutional holdings are 83.09M shares, increasing 0.91% quarter-over-quarter.
Labcorp Holdings Inc. provides comprehensive laboratory services that help doctors, hospitals, pharmaceutical companies, researchers and patients make clear and confident decisions. The Company provides insights and accelerates to improve health and improve lives through its unparalleled diagnostics and drug development capabilities. The Company operates through two segments: Diagnostics Laboratories (Dx) and Biopharma Laboratory Services (BLS). The Diagnostics Laboratories segment includes routine testing and specialty/esoteric testing. Dx operates through a network of patient service centers, branches, rapid response laboratories, primary laboratories, and specialty laboratories. The Biopharma Laboratory Services segment consists of early development research laboratories and central laboratory services. The Company is focused on four primary specialty testing areas, such as oncology, women's health, autoimmune disease, and neurology.
Ticker SymbolLH
CompanyLabcorp Holdings Inc
CEOSchechter (Adam H)
Websitehttps://www.labcorp.com/
FAQs
What is the current price of Labcorp Holdings Inc (LH)?
The current price of Labcorp Holdings Inc (LH) is 260.700.
What is the symbol of Labcorp Holdings Inc?
The ticker symbol of Labcorp Holdings Inc is LH.
What is the 52-week high of Labcorp Holdings Inc?
The 52-week high of Labcorp Holdings Inc is 293.720.
What is the 52-week low of Labcorp Holdings Inc?
The 52-week low of Labcorp Holdings Inc is 209.375.
What is the market capitalization of Labcorp Holdings Inc?
The market capitalization of Labcorp Holdings Inc is 21.64B.
What is the net income of Labcorp Holdings Inc?
The net income of Labcorp Holdings Inc is 746.00M.
Is Labcorp Holdings Inc (LH) currently rated as Buy, Hold, or Sell?
According to analysts, Labcorp Holdings Inc (LH) has an overall rating of Buy, with a price target of 299.753.
What is the Earnings Per Share (EPS TTM) of Labcorp Holdings Inc (LH)?
The Earnings Per Share (EPS TTM) of Labcorp Holdings Inc (LH) is 10.252.